血液净化护理杂志投稿

血液净化护理杂志投稿

该杂志如何投稿

血液净化在日常生活中也称透析。它的涵义是：把患者的血液引出身体外并通过一种净化装置，除去其中某些致病物质，净化血液，达到治疗疾病的目的。血液净化应包括：血液透析、血液滤过、血液灌流、血浆置换、免疫吸附等。腹膜透析虽然没有将血液引出体外，但其原理都是一样的。血液透析只是治疗慢性肾衰的方法之一。

血液净化一般是指血液透析，针对肾脏功能衰竭的患者。血液净化技术可以清除肌酐和尿素氮，进而减少尿毒症的发生。它是治疗肾脏疾病到了终末期的一个办法。常见的血液净化的方式包括血液透析、腹膜透析、血液灌流、血浆置换、血液滤过。

如果想投稿中国血液净化杂志，你可以按照他的要求以及程序往他的邮箱里直接投。

血液净化护理杂志

冠以“中华。。。”字样的，属于中华人民共和国卫生部主办的或委托办的医学类期刊均是国家级的核心期刊。比如:中华医学、中华外科学、中华病理学。。。，祝你心想事成！

判断一本期刊是不是国家级医学学术期刊，只需要到中国记者网上（新闻出版署的网站）上面输入该期刊的名字，如果主管单位是国家级部位或者机构的就是国家级期刊，否则就不是。如果想在国家级期刊上发表文章，可以找我，我可以协助，发表时间快，周期短，易发表，价格低。详见我空间的联系方式吧

中国血液净化杂志怎么投稿可以把你的稿写好以后经过专家帮你审核以后确实觉得挺好，然后往中国血液净化杂志上投稿。

首先，登录中国期刊全文数据库、万方数据库或者 维普数据库（此为中国三大专业文献数据库）或国外Pubmed/Medline等国外专业数据库，然后搜索相关的文献，写出您的文章。其次，再去以上数据库中搜索相关专业期刊编辑部信息（国家级或是非国家级，核心或者非核心，统计源或者非统计源期刊等等），找到投稿联系方式，这样的方法避免网上很多钓鱼网站，确保您投稿的期刊是合法的。最后,祝好运。欢迎交流。静石医疗，竭诚为您服务。

血液净化护理杂志投稿要求

首先，登录中国期刊全文数据库、万方数据库或者 维普数据库（此为中国三大专业文献数据库）或国外Pubmed/Medline等国外专业数据库，然后搜索相关的文献，写出您的文章。其次，再去以上数据库中搜索相关专业期刊编辑部信息（国家级或是非国家级，核心或者非核心，统计源或者非统计源期刊等等），找到投稿联系方式，这样的方法避免网上很多钓鱼网站，确保您投稿的期刊是合法的。最后,祝好运。欢迎交流。静石医疗，竭诚为您服务。

血液净化一般是指血液透析，针对肾脏功能衰竭的患者。血液净化技术可以清除肌酐和尿素氮，进而减少尿毒症的发生。它是治疗肾脏疾病到了终末期的一个办法。常见的血液净化的方式包括血液透析、腹膜透析、血液灌流、血浆置换、血液滤过。

国家级就是，主办单位是是国家级的期刊。这类期刊大多都会加上中国，中华在名称的最前面。一看便知。

血液净化在日常生活中也称透析。它的涵义是：把患者的血液引出身体外并通过一种净化装置，除去其中某些致病物质，净化血液，达到治疗疾病的目的。血液净化应包括：血液透析、血液滤过、血液灌流、血浆置换、免疫吸附等。腹膜透析虽然没有将血液引出体外，但其原理都是一样的。血液透析只是治疗慢性肾衰的方法之一。

血液净化护理杂志投稿邮箱

首先，登录中国期刊全文数据库、万方数据库或者 维普数据库（此为中国三大专业文献数据库）或国外Pubmed/Medline等国外专业数据库，然后搜索相关的文献，写出您的文章。其次，再去以上数据库中搜索相关专业期刊编辑部信息（国家级或是非国家级，核心或者非核心，统计源或者非统计源期刊等等），找到投稿联系方式，这样的方法避免网上很多钓鱼网站，确保您投稿的期刊是合法的。最后,祝好运。欢迎交流。静石医疗，竭诚为您服务。

_pdf?id=CRg9AAAAEBAJ&output=pdf&sig=ZDBOJ4lcW-naTeirbPcgYWVlaLg给你找了一篇有10页那么长是PDF格式的

该杂志如何投稿

冠以“中华。。。”字样的，属于中华人民共和国卫生部主办的或委托办的医学类期刊均是国家级的核心期刊。比如:中华医学、中华外科学、中华病理学。。。，祝你心想事成！

血液净化护理杂志投稿经验

中国血液净化杂志怎么投稿可以把你的稿写好以后经过专家帮你审核以后确实觉得挺好，然后往中国血液净化杂志上投稿。

Blood purification pharmacokinetics Shanghai Jiaotong University College of Medicine subsidiary Ruijin Hospital kidney Chen Nan-J) N FWR; t Blood purification technology in clinical treatment of acute and chronic renal failure has been nearly half a century, and in critically ill patients, such as acute renal failure (ARF) in the treatment of continuous renal replacement therapy (CRRT) more traditional intermittent hemodialysis greater advantages, its clinical application is gradually expanded from the traditional kidney renal replacement to support development, participate in a multidisciplinary critical severe _ (HwU> Whether or ARF in patients with CRF usually kinds of medication, drugs in the application of these patients should be in accordance with its residual renal function adjustment, and at the same time, blood purification and changed the drug metabolism in patients with these conditions, particularly in critically ill patients, such as failure to consider this factor, medication adjustment programmes, the consequences could be Q: bKT # \ 1) from the following three aspects of the assessment of patients with blood purification P (rS - `I First, the nature of drug j1ZFsTFMWp 1, renal clearance in the proportion of drug: drug in the body's overall clearance rate is the body organ system capacity to remove the sum of drugs, including liver, kidney, as well as other metabolic If drugs mainly through kidney removal, which is usually to remove CRRT part of the in vitro clear / removal of the overall ≥ 25 ~ 30%, it is necessary to adjust the Pio ^ 5j hB6 2, protein binding rate: drug free with biological activity and can be removed filtration, plasma protein binding is the high rate of drugs (such as digitalis glycosides drug, warfarin, ) are difficult to remove CRRT Protein binding rate can be affected by many factors, the theoretical value and the actual situation may have some ! A! \ S / x4 3, molecular weight: small molecular diffusion easy to be adopted by dialysis membrane pore, drug removals and molecular size inversely proportional to macromolecules often convection through, unless more than its molecular weight film hole size, or ultrafiltration rate associated with the Most of the molecular weight of less than 500 drug Da, Da little more than Extension of high-flux dialysis membrane and time of removal can be improved 'T [zh # v> S 4, the volume of distribution (Vd): in vivo drug representatives of the extent of the Vd representative of the high rate of drug organizations with high clearance rate is Vd patients with severe and theoretical value can be very different, but there are individual Drug Vd ≤ 1 L / kg easy clearance, ≥ 2 L / kg difficult to be High flow could be higher IHD Vd drug rapidly cleared from plasma, serum concentration decreased, but only in a dialysis drug remove a small part in the two dialysis between plasma concentration will quickly CRRT continued slow clearance high Vd drugs, the process of drug plasma from the organizations to re-distribution, the change in the plasma concentration of ( 3, blood and dialysis fluid flow rate: the faster the velocity, the more easily access drug dialysis membrane into the dialysis solution in the dialysis fluid flow faster, drug dialysis fluid outflow from the faster to maintain the required gradient # J a `+ w) Third, the patient's own | (a] P = 9X, Cefaclor 1 25 24-35 25-5 tid not adjusted to 25 sU? "V Cefoperazone 6-5 90 14-20 1-2 q12h thoroughly after delivery without adjustment?,: # 9 Cefuroxime 2 33 13-18 75-5 q8h thoroughly after administration 0 q12h * i? RJH Ceftazidime 2 17 28-4 1-0 q8h 0 1-0 q24-48h YxE bg (Y Amikacin 4-3 <5 22-29 5mg/kg q12h 2 / 3 of the normal 30-70% q12-18h wI! + L & Q Tobramycin 5 <5 22-33 7mg/kg q8h 2 / 3 of the normal 30-70% q12h lC = N: = Mu Ciprofloxacin 3-6 20-40 5 5-75 q12h 25 q12h 2 q12h, $ h (fM8GC Levofloxacin 4-8 24-38 1-5 5 q24h 25-50% 50% + T, H & # Imipenem 1 13-21 17-3 5-0 q6h thoroughly after administration 50 percent - J "qrp Z ^ Vancomycin 6-8 10-50 47-1 5 q6h 5 q48-q24-96h 5% 48h c X: 3 30 4 losartan 50mg qd-q12h unclear hundred percent jq57C)) X 2 Benazepril 22 95 15 10mg qd not 50-75% uw K h Monopril 12 95 15 10mg qd not 100% [T'yc: = Atenolol 7 45-60 5-10 50-100mg qd 25-50mg 50% q48h s ULIrYRA The name of the drug half-life F Ze: co8Mu (H) protein binding 0zw + @ l ` (%) Vd `" a? A 5] k (L / Kg) renal function f) * NX After the normal dose HD ^ fs m6 f)) SUPPLEMENTARY of CRRT j ~ Q) F | i8 Carvedilol 5-8 95 1-2 25-50mg q12-24h not 100 percent [6AHaOhR ' Nifedipine 4-5 97 4 10-20mg q6-8h not 100%> s & XX, w Amlodipine 35-50 95 21 5mg qd not 100 percent 1p8: 1) q Felodipine 10-14 99 9-10 10mg qd not 100% gs? 8Wzh90 * Digoxin 36-44 20-30 5-8 25-5mg qd not 25-75% q36h H4t) + (: D ' Low-molecular-weight heparin 2-0 unclear 06-13 30-40mg bid unclear 100% p "2m9 0IO Warfarin 34-35 99 15 load 10-15 mg of 2-10 mg qd not iHPUmTus not -- Azathioprine 16-1 20 55-8 5-5mg/kg q24h 25mg/kg 75% yq?] V7 ~ Cyclophosphamide 4-5 14-20 5-1 1-5mg/kg qd 1 / 2 dose of 100% Z:! IX ^ q;) n Vincristine 1-5 75 5-11 4mg / sq m unclear 100% I! P4 (3skAB Prednisone 5-5 80 2 5-60mg qd not 100% X x_ tpC? Prednisolone 5-5 80 2 5-60mg qd need 100 percent OZf6/10O / A prednisone 9-0 40-60 2-5 4-48mg qd not 100 percent [@ / /) # 5v Insulin 2-4 5 15 Indefinite not 75% `([R j M` Acarbose 3-9 15 32 50-200mg tid unclear avoid / 'ZKST4 Effects of Fluvastatin small 5-1 98 42 2-10mg qd unclear 100% k O1)? DWpa Simvastatin 2> 95 mg qd unclear 5-40 unclear 100%

如果想投稿中国血液净化杂志，你可以按照他的要求以及程序往他的邮箱里直接投。

在欧美国家，血液净化早已成为人们健康护理的必备选项！在德国，血液净化疗法已经在保险允许范围内有着40年以上的使用历史，每年有超过20万人定期进行血液净化，许多公司白领、企业领导、国家领导人等每隔一段时间都会进行血液净化，以便及时排除体内堆积的毒素。血液净化是通过将人体血浆从血液中分离出来，然后通过独有的分子筛和具有生物吸附功能的纳米超离子纤维膜，进行分离或吸附的二级处理，直接清除血浆中的有毒有害等致病物质。当血液经过净化吸附滤芯后，致病因子会被吸附在滤芯中，从血液中隔离出来，健康血液又回流到体内。它能够有效降低胆固醇、改善血管弹性功能，清除血管凝集分子/发炎分子，降低血液粘稠度，清除致癌因子。去除血浆中代谢毒物，提高细胞活性，保护心肌，修复受损的血管，焕发机体生命力，有效防止早衰，预防心脑血管疾病等。目前该项目已纳入国内精准健康管理体系。